1. Home
  2. PX vs INDV Comparison

PX vs INDV Comparison

Compare PX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PX
  • INDV
  • Stock Information
  • Founded
  • PX 1992
  • INDV 1994
  • Country
  • PX United States
  • INDV United States
  • Employees
  • PX N/A
  • INDV N/A
  • Industry
  • PX Investment Managers
  • INDV Biotechnology: Pharmaceutical Preparations
  • Sector
  • PX Finance
  • INDV Health Care
  • Exchange
  • PX Nasdaq
  • INDV Nasdaq
  • Market Cap
  • PX 1.4B
  • INDV 1.3B
  • IPO Year
  • PX 2021
  • INDV N/A
  • Fundamental
  • Price
  • PX $13.40
  • INDV $11.65
  • Analyst Decision
  • PX Buy
  • INDV Strong Buy
  • Analyst Count
  • PX 9
  • INDV 2
  • Target Price
  • PX $13.78
  • INDV $16.00
  • AVG Volume (30 Days)
  • PX 610.6K
  • INDV 1.2M
  • Earning Date
  • PX 02-27-2025
  • INDV 02-20-2025
  • Dividend Yield
  • PX 1.05%
  • INDV N/A
  • EPS Growth
  • PX N/A
  • INDV N/A
  • EPS
  • PX 0.10
  • INDV N/A
  • Revenue
  • PX $274,501,000.00
  • INDV $1,182,000,000.00
  • Revenue This Year
  • PX $20.64
  • INDV $6.13
  • Revenue Next Year
  • PX $5.44
  • INDV N/A
  • P/E Ratio
  • PX $132.60
  • INDV N/A
  • Revenue Growth
  • PX 15.82
  • INDV 13.44
  • 52 Week Low
  • PX $7.08
  • INDV $7.33
  • 52 Week High
  • PX $14.28
  • INDV $23.22
  • Technical
  • Relative Strength Index (RSI)
  • PX 57.25
  • INDV 49.25
  • Support Level
  • PX $12.51
  • INDV $11.39
  • Resistance Level
  • PX $13.56
  • INDV $12.75
  • Average True Range (ATR)
  • PX 0.35
  • INDV 0.33
  • MACD
  • PX 0.05
  • INDV -0.13
  • Stochastic Oscillator
  • PX 83.69
  • INDV 34.52

About PX P10 Inc.

P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Share on Social Networks: